Investors Panicked on CoreWeave. Why It Might Be Time to Get Greedy

CoreWeave shares have staged a sharp recovery, rising about 61% from late‑March lows after earlier plunging just over 60%, driven by fresh AI customer wins, large hyperscale deals and upbeat analyst upgrades. Upgrades from Macquarie ($125 target) and Wolfe Research ($150) reinforce investor interest, while the company’s priority access to Nvidia GPUs and its “Mission Control” AI operating system are highlighted as durable competitive advantages. The rally signals renewed appetite for AI infrastructure and semiconductor–adjacent names, though risks include significant debt and exposure if the AI demand cycle cools. At roughly 9.4x price‑to‑sales, the stock is portrayed as potentially reasonably valued given secular demand for compute.